Grant: Discovery Grants Program - Individual
École Polytechnique de Montréal
$54,000.00
surface bioconjugaison for regenerative medicine applications
EF 2012-13
Résumé
One main challenge in regenerative medicine resides in the precise and efficient control of the interactions between cells and materials. Within the last decade, the development of new materials with potential to serve as scaffolds to support cell growth has undergone rapid expansion. In that context, novel vascular therapies aiming at replacing small diameter arteries are now developed to treat diseased vessels, the major cause of illness, disability and death in Canada. However, current issues include the lack of prosthetic endothelialization that is limited by the intrinsic properties of the biomaterial composing the grafts, and directly related to high occurrence of graft thrombosis and intimal hyperplasia.
This research program focuses on controlling endothelial cell growth and phenotype on polyethylenterephtalate (PET) substrate for future applications in vascular therapy. To do so, we propose to tether fully bioactive epidermal and vascular endothelial growth factors (EGF and VEGF) onto functionalized PET surfaces in an oriented fashion as both growth factors (GFs) were shown to be absolutely necessary for proper angiogenesis and vasculogenesis. The program will carefully investigate the potential of two distinct approaches for GF bioconjugation, i.e., the use of a de novo designed coiled-coil peptide system or, alternatively, poly-glutamate tags. These strategies will allow to not only evaluate the effect of prolonged cell exposure to tethered GFs or GF cocktails but also compare signaling pathway activation and cellular outcomes to those obtained by classical soluble GF supply. New biotechnology tools aiming at rapidly assaying protein concentration and bioactivity, will also be developed to speed up the study of the fundamental points investigated in this research program. This research program will thus train HQP in an emerging interdisciplinary field integrating surface chemistry, protein production, cell culture, protein characterization and bio-engineering approaches. HQP will be daily-exposed to cutting-edge technologies that are already implanted in many biopharmaceutical companies and governmental research institutions.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
314056-2010
Name nom
DeCrescenzo, Gregory
Department département
Génie chimique
Organization id
64
Institution établissement
École Polytechnique de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2010
Award amount
54000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Partie
3
Nb partie
5
Application title
surface bioconjugaison for regenerative medicine applications
Keyword
NSERC
Application summary
One main challenge in regenerative medicine resides in the precise and efficient control of the interactions between cells and materials. Within the last decade, the development of new materials with potential to serve as scaffolds to support cell growth has undergone rapid expansion. In that context, novel vascular therapies aiming at replacing small diameter arteries are now developed to treat diseased vessels, the major cause of illness, disability and death in Canada. However, current issues include the lack of prosthetic endothelialization that is limited by the intrinsic properties of the biomaterial composing the grafts, and directly related to high occurrence of graft thrombosis and intimal hyperplasia.
This research program focuses on controlling endothelial cell growth and phenotype on polyethylenterephtalate (PET) substrate for future applications in vascular therapy. To do so, we propose to tether fully bioactive epidermal and vascular endothelial growth factors (EGF and VEGF) onto functionalized PET surfaces in an oriented fashion as both growth factors (GFs) were shown to be absolutely necessary for proper angiogenesis and vasculogenesis. The program will carefully investigate the potential of two distinct approaches for GF bioconjugation, i.e., the use of a de novo designed coiled-coil peptide system or, alternatively, poly-glutamate tags. These strategies will allow to not only evaluate the effect of prolonged cell exposure to tethered GFs or GF cocktails but also compare signaling pathway activation and cellular outcomes to those obtained by classical soluble GF supply. New biotechnology tools aiming at rapidly assaying protein concentration and bioactivity, will also be developed to speed up the study of the fundamental points investigated in this research program. This research program will thus train HQP in an emerging interdisciplinary field integrating surface chemistry, protein production, cell culture, protein characterization and bio-engineering approaches. HQP will be daily-exposed to cutting-edge technologies that are already implanted in many biopharmaceutical companies and governmental research institutions.